SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED)
Clinical trial NCT00798213 · TERMINATED
Trial details
- NCT number
- NCT00798213
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2010-04-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.